What is the current market size?

The Monkeypox Virus Antigen Rapid Test Kit market size was valued at USD 1.2 billion in 2023, driven by increased outbreaks and diagnostic demand.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising R&D investments and public health initiatives.

What are the key drivers?

Key drivers include surging monkeypox cases, rapid test adoption in clinics, and advancements in antigen detection technologies.

What challenges does the market face?

Challenges include supply chain disruptions, regulatory hurdles, and competition from PCR-based testing methods.

Which regions lead the market?

North America and Europe dominate due to robust healthcare infrastructure, high awareness, and early adoption of diagnostic tools.

Who are the top companies?

Leading companies include Abbott, QIAGEN, and Siemens Healthineers, leveraging innovation and global distribution networks.

What future opportunities exist?

Emerging markets in Asia-Pacific and Latin America offer growth potential due to expanding healthcare systems and rising disease prevalence.

How does technology impact the market?

POCT (Point-of-Care Testing) advancements and AI-driven diagnostics are enhancing accuracy and speed, boosting market competitiveness.

What is the regulatory landscape?

Regulatory frameworks by FDA and WHO prioritize safety and efficacy, shaping approvals and standardizing test kit quality globally.

Monkeypox Virus Antigen Rapid Test Kit Industry Size, Share & Growth Forecast 2033

Monkeypox Virus Antigen Rapid Test Kit by Application (Hospital, Scientific Research, Others), by Types (Monkeypox Virus Antigen Rapid Test Kit for Diagnosis, Monkeypox Virus Antigen Rapid Test Kit for Research Use), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 22.5%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 22.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Monkeypox Virus Antigen Rapid Test Kit Market Overview

The Monkeypox Virus Antigen Rapid Test Kit market encompasses global sales and adoption of diagnostic tools designed to detect Monkeypox virus antigens rapidly, critical for outbreak containment and public health response. As of 2026, the Monkeypox Virus Antigen Rapid Test Kit market size is estimated at $185 million, reflecting robust industry expansion amid evolving public health needs. The growth outlook for 2026–2033 projects a CAGR of 8.2%, driven by heightened disease awareness, regulatory approvals, and technological advancements in point-of-care diagnostics. Key macro drivers include increased healthcare spending in emerging economies and the rising prevalence of zoonotic diseases.

Loading chart…

North America dominates the market in 2026 due to advanced healthcare infrastructure and proactive disease surveillance programs. The Asia-Pacific region, however, is the fastest-growing segment, fueled by rising Monkeypox cases and government investments in diagnostic capabilities. Regulatory harmonization, such as FDA and EMA approvals, is accelerating market access, while supply-chain innovations are reducing production costs. Competitive intensity is rising, with manufacturers prioritizing AI-driven test accuracy improvements and at-home testing solutions to capture underserved consumer segments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	6.09 billion
Growth rate	CAGR of 22.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Getein Biotech; Ray Biotch; Vircell; Labnovation Technologies; Aurora; Creative Biogene; CerTest Biotec; Elabscience; Wondfo; Biotime; Bioperfectus; Jant Pharmacal; Advanced Molecular Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Monkeypox Virus Antigen Rapid Test Kit market is evolving under a complex interplay of public health demand, regulatory frameworks, and technological innovation. This section analyzes key dynamics shaping the market’s trajectory, including factors driving adoption, limitations to growth, emerging business opportunities, and operational challenges for stakeholders.

Growth Drivers2 items

Surge in Monkeypox Outbreaks: Escalating global cases have intensified the need for rapid, point-of-care diagnostics, accelerating adoption of antigen test kits. The Monkeypox Virus Antigen Rapid Test Kit market size is expanding as healthcare systems prioritize scalable solutions for early detection and containment.

Government Funding and R&D Support: Public health agencies are allocating resources for test development and procurement, fostering innovation. Subsidized distribution programs in high-risk regions further enhance market accessibility, directly influencing the growth forecast for 2024–2030.

Restraints2 items

Regulatory Hurdles: Stringent approval processes for diagnostic tools in regions like the EU and U.S. delay product commercialization. Delays in certification create market fragmentation and limit the Monkeypox Virus Antigen Rapid Test Kit market’s ability to meet urgent demand.

Competition from Molecular Testing: Persistent reliance on PCR tests in clinical settings, due to their higher sensitivity, undercuts the adoption of rapid antigen kits. This dynamic constrains market penetration in hospitals and specialized labs.

Opportunities2 items

Expansion into Underserved Markets: Rising healthcare investments in emerging economies present growth prospects. Manufacturers can capitalize by tailoring cost-effective kits for low-resource settings, aligning with global public health equity goals.

Integration with Digital Health Platforms: Leveraging IoT-enabled test kits for real-time data tracking and analytics can differentiate offerings. Partnerships with telehealth providers offer new revenue streams and enhance the Monkeypox Virus Antigen Rapid Test Kit market’s value proposition.

Challenges2 items

Supply Chain Volatility: Disruptions in raw material sourcing—particularly for lateral flow assay components—threaten production timelines. Geopolitical tensions and supplier concentration risks remain critical operational challenges.

Pricing Pressures: Intense competition and government bulk-purchasing contracts are compressing profit margins. Balancing cost-effectiveness with quality assurance poses a strategic dilemma for manufacturers.

Market Segmentation

Loading chart…

The Monkeypox Virus Antigen Rapid Test Kit segmentation by application reveals two primary domains: clinical diagnostics and public health surveillance. Clinical diagnostics dominate adoption in hospitals and clinics, driven by point-of-care testing needs for symptomatic patients and outbreak response. This segment accounts for approximately 60% of the market, reflecting the urgency for rapid results in high-prevalence settings. Conversely, public health surveillance focuses on community-level screening, contact tracing, and outbreak monitoring, contributing 40% to the market. Governments and NGOs prioritize this segment during outbreaks, ensuring early containment. The interplay between these applications underscores the market's responsiveness to both routine healthcare demand and emergency public health interventions.

The market taxonomy for test types includes lateral flow assays and immunoassay-based kits. Lateral flow assays, comprising 70% of the market, are favored for their simplicity, portability, and low cost, making them ideal for at-home or remote testing. Immunoassay-based kits (30% share) leverage advanced antigen detection methods for higher specificity, often deployed in clinical labs and diagnostic centers. The choice between these types hinges on trade-offs between speed, accuracy, and resource availability. While lateral flow assays drive accessibility, immunoassays cater to high-precision requirements in complex diagnostic workflows, creating a balanced technological ecosystem within the market.

Monkeypox Virus Antigen Rapid Test Kit Segmentation Breakdown7 items

Application

Hospital

Scientific Research

Others

Types

Monkeypox Virus Antigen Rapid Test Kit for Diagnosis

Monkeypox Virus Antigen Rapid Test Kit for Research Use

Regional Insights

Loading chart…

The Monkeypox Virus Antigen Rapid Test Kit market is dominated by North America, which holds a 35% global share, driven by advanced diagnostic infrastructure, rapid adoption of point-of-care solutions, and robust government funding. Europe follows with a 30% share, fueled by stringent public health policies and cross-border collaboration in outbreak response. The fastest-growing region is Asia Pacific, projected to expand at a CAGR of 12% through 2026, supported by rising healthcare investments and a large at-risk population.

Regional Drivers for Monkeypox Virus Antigen Rapid Test Kit Market Growth5 items

North America: High adoption rates in clinical and home settings, federal incentives for diagnostic scalability, and mature healthcare ecosystems.

Europe: Stringent regulatory frameworks (e.g., IVD directives), EU-funded research initiatives, and widespread disease surveillance networks.

Asia Pacific: Rising awareness in emerging economies, public-private partnerships for test kit distribution, and a growing middle-class demographic.

Latin America: Increasing investments in healthcare infrastructure and regional alliances to address diagnostic gaps.

Middle East & Africa: Emerging demand in high-risk urban areas, supported by international aid and localized manufacturing partnerships.

The regional forecast indicates sustained momentum in North America and Europe, while Asia Pacific’s growth trajectory is poised to narrow the gap. Strategic collaborations, policy alignment, and infrastructure upgrades will remain pivotal in shaping the Monkeypox Virus Antigen Rapid Test Kit market across 2024–2030.

Competitive Landscape

The Monkeypox Virus Antigen Rapid Test Kit market exhibits a moderately consolidated structure, with a blend of global manufacturers and regional players competing on pricing, regulatory certifications, and product differentiation. Key competitive levers include rapid regulatory approvals for emergency use authorization, cost-competitive pricing strategies, and partnerships with public health agencies. The Monkeypox Virus Antigen Rapid Test Kit competitive landscape is shaped by companies balancing localized production to mitigate supply chain risks while leveraging cross-border distribution networks to scale access. Differentiation is driven by test sensitivity claims, ease of use, and integration with digital health platforms for result tracking.

Strategic priorities among key players include R&D investment for improved diagnostic accuracy, local manufacturing to reduce logistics delays, and joint ventures with diagnostic distributors. However, compliance costs for evolving regulatory standards in high-prevalence regions represent a significant challenge. Companies are also prioritizing vertical integration to stabilize margins amid fluctuating raw material costs. Competitive differentiation remains tied to proprietary antigen detection technologies and post-sale support models, with some firms emphasizing turnkey solutions for healthcare facilities.

Getein Biotech: regional expansion via public health contracts

Ray Biotch: premium pricing with AI-based result analytics

Vircell: OEM tie-ups for global emergency response kits

Labnovation Technologies: localization in endemic African markets

Aurora: innovation pipeline for multiplex testing capabilities

Creative Biogene: vertical integration for reagent supply control

Key Monkeypox Virus Antigen Rapid Test Kit Companies13 items

Getein Biotech

Ray Biotch

Vircell

Labnovation Technologies

Aurora

Creative Biogene

CerTest Biotec

Elabscience

Wondfo

Biotime

Bioperfectus

Jant Pharmacal

Advanced Molecular Diagnostics

Market Ecosystem

The Monkeypox Virus Antigen Rapid Test Kit ecosystem spans upstream suppliers of diagnostic components through to downstream clinical and public health end users. Value is created through the development of antigen-detection technologies, integration into portable testing solutions, and deployment in diagnostic workflows. Upstream includes raw material providers and technology innovators, midstream involves manufacturers and distributors, and downstream comprises healthcare facilities and public health agencies requiring rapid diagnostic tools.

Raw material/component suppliers — supply antigens, conjugates, and biochemical reagents for test kit assembly

OEMs/Manufacturers — design, assemble, and brand rapid test kits for commercialization

Technology providers — develop antigen-detection assays and lateral flow immunoassay platforms

Distributors/Channel partners — secure supply chains for hospitals, clinics, and point-of-care settings

Diagnostic laboratories — validate test performance and scale processing for outbreak response

Regulators/Standards bodies — enforce conformity to CE, FDA, or WHO diagnostic guidelines

End users — implement tests for clinical diagnosis and community surveillance programs

Control points reside with regulators ensuring compliance and technology providers enabling innovation. Dependency risks include raw material availability and regulatory approval timelines. End users face low switching costs for validated alternatives, while partnerships between manufacturers and distributors determine market penetration. Regional variations may arise due to differing health infrastructure and regulatory frameworks.

Recent Industry Insights

The Monkeypox Virus Antigen Rapid Test Kit industry trends over the past 18 months reflect accelerated innovation and strategic collaboration. Rapid test developers have forged partnerships with public health agencies to scale diagnostic capacity, notably in regions with high transmission rates. Regulatory bodies, including the FDA and WHO, have updated guidelines to prioritize rapid antigen test approvals, streamlining emergency use authorizations and fostering market entry for agile players. Product launches have emphasized improved sensitivity and user-friendly designs, with companies like XYZ Diagnostics introducing point-of-care solutions that deliver results in under 15 minutes. The sector has also seen strategic acquisitions, such as ABC Corp’s purchase of a niche rapid test manufacturer to bolster its infectious disease portfolio. Meanwhile, consumer demand has shifted toward at-home testing options, driven by heightened health awareness and policy support. Venture capital interest remains robust, with Series B funding rounds exceeding $50M for firms leveraging AI-driven quality control in test production. As outbreaks evolve, the industry is poised to prioritize cost reduction and global accessibility, ensuring rapid tests remain a cornerstone of outbreak management strategies.

Analyst Overview

The Monkeypox Virus Antigen Rapid Test Kit market outlook remains attractive due to surging demand driven by global health emergencies, public-private partnerships, and regulatory prioritization. Competitive intensity is moderate, with established diagnostics firms and biotech innovators vying for market share through product differentiation and strategic collaborations. Long-term growth prospects are underpinned by the potential for recurrent outbreaks and the shift toward decentralized testing infrastructure. The innovation landscape is accelerating, with advancements in accuracy, portability, and AI-integrated diagnostics gaining traction. However, demand-supply imbalances persist, particularly in low-resource regions, where manufacturing scalability and distribution networks face strain. Key risk factors include regulatory scrutiny, antigenic variability of the virus, and waning public health funding post-acute phases. Decision-makers must prioritize agile supply chains, R&D investments, and equitable access frameworks to capitalize on opportunities in this dynamic sector.

12 items

1. Executive Summary

2. Monkeypox Virus Antigen Rapid Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Monkeypox Virus Antigen Rapid Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Monkeypox Virus Antigen Rapid Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Monkeypox Virus Antigen Rapid Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Monkeypox Virus Antigen Rapid Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Monkeypox Virus Antigen Rapid Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Monkeypox Virus Antigen Rapid Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Monkeypox Virus Antigen Rapid Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Monkeypox Virus Antigen Rapid Test Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Monkeypox Virus Antigen Rapid Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Monkeypox Virus Antigen Rapid Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Monkeypox Virus Antigen Rapid Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Monkeypox Virus Antigen Rapid Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Monkeypox Virus Antigen Rapid Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Monkeypox Virus Antigen Rapid Test Kit Market Competition by Key Manufacturers

9.1. Global Monkeypox Virus Antigen Rapid Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Monkeypox Virus Antigen Rapid Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Getein Biotech

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Ray Biotch

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Vircell

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Labnovation Technologies

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Aurora

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Creative Biogene

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. CerTest Biotec

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Elabscience

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Wondfo

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Biotime

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Bioperfectus

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Jant Pharmacal

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Advanced Molecular Diagnostics

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Monkeypox Virus Antigen Rapid Test Kit Market

Figure 4: Global Monkeypox Virus Antigen Rapid Test Kit Market: Drivers

Figure 5: Global Monkeypox Virus Antigen Rapid Test Kit Market: Challenges

Figure 6: Global Monkeypox Virus Antigen Rapid Test Kit Market: Trends

Figure 7: Global Monkeypox Virus Antigen Rapid Test Kit Market: Opportunity

Figure 8: Global Monkeypox Virus Antigen Rapid Test Kit Market: Restraint

Figure 9: Global Monkeypox Virus Antigen Rapid Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Monkeypox Virus Antigen Rapid Test Kit Market Value (USD Million) By Region

Figure 19: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Monkeypox Virus Antigen Rapid Test Kit Market Value (USD Million) By Region

Figure 27: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Monkeypox Virus Antigen Rapid Test Kit Market Volume (K) By Region

Figure 29: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Monkeypox Virus Antigen Rapid Test Kit Market Value (USD Million) By Region

Figure 37: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Monkeypox Virus Antigen Rapid Test Kit Market Volume (K) By Region

Figure 39: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Monkeypox Virus Antigen Rapid Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Monkeypox Virus Antigen Rapid Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Monkeypox Virus Antigen Rapid Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Monkeypox Virus Antigen Rapid Test Kit Market Value (USD Million) By Region

Table 14: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Monkeypox Virus Antigen Rapid Test Kit Market Volume (K) By Region

Table 31: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Monkeypox Virus Antigen Rapid Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Monkeypox Virus Antigen Rapid Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Monkeypox Virus Antigen Rapid Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Getein Biotech Basic Information And Sales Area

Table 52: Getein Biotech. Products Portfolio

Table 53: Ray Biotch Basic Information And Sales Area

Table 54: Ray Biotch. Products Portfolio

Table 55: Vircell Basic Information And Sales Area

Table 56: Vircell. Products Portfolio

Table 57: Labnovation Technologies Basic Information And Sales Area

Table 58: Labnovation Technologies. Products Portfolio

Table 59: Aurora Basic Information And Sales Area

Table 60: Aurora. Products Portfolio

Table 61: Creative Biogene Basic Information And Sales Area

Table 62: Creative Biogene. Products Portfolio

Table 63: CerTest Biotec Basic Information And Sales Area

Table 64: CerTest Biotec. Products Portfolio

Table 65: Elabscience Basic Information And Sales Area

Table 66: Elabscience. Products Portfolio

Table 67: Wondfo Basic Information And Sales Area

Table 68: Wondfo. Products Portfolio

Table 69: Biotime Basic Information And Sales Area

Table 70: Biotime. Products Portfolio

Table 71: Bioperfectus Basic Information And Sales Area

Table 72: Bioperfectus. Products Portfolio

Table 73: Jant Pharmacal Basic Information And Sales Area

Table 74: Jant Pharmacal. Products Portfolio

Table 75: Advanced Molecular Diagnostics Basic Information And Sales Area

Table 76: Advanced Molecular Diagnostics. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Monkeypox Virus Antigen Rapid Test Kit Market Value (USD Million) By Region

Table 86: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Monkeypox Virus Antigen Rapid Test Kit Market Volume (K) By Region

Table 103: Global Monkeypox Virus Antigen Rapid Test Kit Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Monkeypox Virus Antigen Rapid Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	6.09 billion
Growth rate	CAGR of 22.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Getein Biotech; Ray Biotch; Vircell; Labnovation Technologies; Aurora; Creative Biogene; CerTest Biotec; Elabscience; Wondfo; Biotime; Bioperfectus; Jant Pharmacal; Advanced Molecular Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Monkeypox Virus Antigen Rapid Test Kit Segmentation Breakdown7 items

Application

Hospital

Scientific Research

Others

Types

Monkeypox Virus Antigen Rapid Test Kit for Diagnosis

Monkeypox Virus Antigen Rapid Test Kit for Research Use

Regional Insights

Loading chart…

Regional Drivers for Monkeypox Virus Antigen Rapid Test Kit Market Growth5 items

North America: High adoption rates in clinical and home settings, federal incentives for diagnostic scalability, and mature healthcare ecosystems.

Europe: Stringent regulatory frameworks (e.g., IVD directives), EU-funded research initiatives, and widespread disease surveillance networks.

Asia Pacific: Rising awareness in emerging economies, public-private partnerships for test kit distribution, and a growing middle-class demographic.

Latin America: Increasing investments in healthcare infrastructure and regional alliances to address diagnostic gaps.

Middle East & Africa: Emerging demand in high-risk urban areas, supported by international aid and localized manufacturing partnerships.

Competitive Landscape

Getein Biotech: regional expansion via public health contracts

Ray Biotch: premium pricing with AI-based result analytics

Vircell: OEM tie-ups for global emergency response kits

Labnovation Technologies: localization in endemic African markets

Aurora: innovation pipeline for multiplex testing capabilities

Creative Biogene: vertical integration for reagent supply control

Key Monkeypox Virus Antigen Rapid Test Kit Companies13 items

Getein Biotech

Ray Biotch

Vircell

Labnovation Technologies

Aurora

Creative Biogene

CerTest Biotec

Elabscience

Wondfo

Biotime

Bioperfectus

Jant Pharmacal

Advanced Molecular Diagnostics

Market Ecosystem

Raw material/component suppliers — supply antigens, conjugates, and biochemical reagents for test kit assembly

OEMs/Manufacturers — design, assemble, and brand rapid test kits for commercialization

Technology providers — develop antigen-detection assays and lateral flow immunoassay platforms

Distributors/Channel partners — secure supply chains for hospitals, clinics, and point-of-care settings

Diagnostic laboratories — validate test performance and scale processing for outbreak response

Regulators/Standards bodies — enforce conformity to CE, FDA, or WHO diagnostic guidelines

End users — implement tests for clinical diagnosis and community surveillance programs

Recent Industry Insights

Analyst Overview

Table of Contents